Literature DB >> 966209

Complications of "slow-K" therapy.

F Sandor.   

Abstract

(1) The failure of ;Slow-K' tablets to disintegrate prevents rapid release but allows them to be trapped by their bulk in the intestine.(2) Two cases are reported. In the first the tablet was trapped in a caecal diverticulum and the patient developed an abcess. In the second, abdominal pain developed which subsided when ;Slow-K' was stopped. Later ;Slow-K' was again started and the patient developed dysphagia.(3) The possibility of abdominal complications with this treatment should be remembered.(4) Effervescent KC1 preparations may replace ;Slow-K' but KC1 supplementation may be necessary only in cardiac disease.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 966209      PMCID: PMC2158348     

Source DB:  PubMed          Journal:  J R Coll Gen Pract        ISSN: 0035-8797


  11 in total

1.  Slow release potassium chloride treatment.

Authors:  A D Howie; R W Strachan
Journal:  Br Med J       Date:  1975-04-26

2.  Risk of congenital abnormality after inadvertent rubella vaccination of pregnant women.

Authors:  J F Modlin; K Herrmann; A D Brandling-Bennett; D L Eddins; G F Hayden
Journal:  N Engl J Med       Date:  1976-04-29       Impact factor: 91.245

3.  Letter: Mouth ulceration and slow-release potassium tablets.

Authors:  B R McAvoy
Journal:  Br Med J       Date:  1974-10-19

4.  Adverse reactions to potassium chloride.

Authors:  D H Lawson
Journal:  Q J Med       Date:  1974-07

5.  Leucocyte electrolytes in cardiac and non-cardiac patients receiving diuretics.

Authors:  R P Edmondson; R D Thomas; P J Hilton; J Patrick; N F Jones
Journal:  Lancet       Date:  1974-01-05       Impact factor: 79.321

6.  Potassium supplements.

Authors:  B E Nordin; R Wilkinson
Journal:  Br Med J       Date:  1970-02-14

7.  Potassium supplements.

Authors:  H E De Wardener; E M Clarkson; J Ford
Journal:  Br Med J       Date:  1969-10-18

8.  Total body and serum potassium during prolonged thiazide therapy for essential hypertension.

Authors:  P R Wilkinson; H Issler; R Hesp; E B Raftery
Journal:  Lancet       Date:  1975-04-05       Impact factor: 79.321

9.  Potassium chloride and intestinal ulceration.

Authors:  V Wynn
Journal:  Lancet       Date:  1965-12-11       Impact factor: 79.321

10.  Total body potassium in long-term frusemide therapy: is potassium supplementation necessary?

Authors:  H J Dargie; K Boddy; A C Kennedy; P C King; P R Read; D M Ward
Journal:  Br Med J       Date:  1974-11-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.